Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04975789 · ClinicalTrials.gov registry record · NA

Visualizations to Improve Pain Communication Between Patients, Interpreters, and Providers

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
61
Enrollment target

NCT04975789: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT04975789 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04975789, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target

Study Summary

The purpose of this study is to pilot test a pain assessment information visualization (InfoViz) tool to facilitate communication about pain severity, location, and quality to increase mutual understanding between patients with limited English proficiency (LEP), interpreters, and providers during pain assessment. 40 participants will be enrolled and can expect to be on study for up to 4 weeks.

Primary Outcome

Feasibility with respect to recruitment will be measured by the percent of eligible patients who enroll.

Interventions

  • OTHER InfoViz

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2021-10-07
Est. Completion 2023-02-23
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT04975789 record still lists

NCT04975789 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which InfoViz is the first listed.

NCT04975789 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04975789 about?

NCT04975789 is a clinical study titled "Visualizations to Improve Pain Communication Between Patients, Interpreters, and Providers". The purpose of this study is to pilot test a pain assessment information visualization (InfoViz) tool to facilitate communication about pain severity, location, and quality to increase mutual understanding between patients with limited English proficiency (LEP), interpreters, and providers during pa...

What is the current status of trial NCT04975789?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2021-10-07. Estimated completion is 2023-02-23.

What interventions are being tested in trial NCT04975789?

The interventions under investigation include: InfoViz (OTHER).

Who is sponsoring clinical trial NCT04975789?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04975789's enrollment target sits among peer trials

61 1164th of 2000 higher than 837 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04975789, the US trial registry maintained by the National Library of Medicine. NCT04975789 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.